Nutriband NTRB 深 沪
等待开盘 09-16 09:30:00 美东时间
6.82
-0.105
-1.52%
华盛通- 最 高7.05
- 今 开6.85
- 成交量 4.56万股
- 最 低 6.72
- 昨 收 6.925
- 总市值 8290.18万
- 52周最高 8.6259
- 市盈率 静 --
- 换手率 0.37%
- 52周最低 2.80
- 委 比 67.57%
- 总股本 1215.57万
- 历史最高 11.78
- 量 比 0.49
- 振 幅 4.77%
- 历史最低 1.53
- 每 手 1
- 风险率 1.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch
Nutriband Inc. has received a Notice of Publication from the USPTO for trademarks related to its abuse-deterrent fentanyl transdermal system. Once approved, the company plans to submit its commercial brand name to the FDA and other international regulators. The product, based on AVERSA™ technology, aims to prevent abuse and misuse of transdermal fentanyl. It has the potential to achieve peak annual US sales of $80 million to $200 million and addr...
09-08 13:00
Nutriband Q2 EPS $(0.07) Up From $(2.12) YoY, Sales $437.514K Down From $622.452K YoY
Nutriband (NASDAQ:NTRB) reported quarterly losses of $(0.07) per share. This is a 96.7 percent increase over losses of $(2.12) per share from the same period last year. The company reported $437.514 thousand in sales this quarter. This is a 29.71 percent decrease over sales of $622.452 thousand the ...
09-05 05:46
Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight
Nutriband Inc. announced that its CEO, Gareth Sheridan, will present at the 2026 Georgia Life Sciences Summit on August 26. The Summit, held in Sandy Springs, Georgia, highlights the state's leadership in life sciences innovation. Nutriband develops abuse-deterrent transdermal technology, with its AVERSA™ technology aiming to prevent drug abuse while ensuring patient access. The company is focused on creating transdermal pharmaceutical products, ...
08-13 11:00
Nutriband Q1 EPS $(0.10) Up From $(0.12) YoY, Sales $433.399K Down From $667.432K YoY
Nutriband (NASDAQ:NTRB) reported quarterly losses of $(0.10) per share. This is a 16.67 percent increase over losses of $(0.12) per share from the same period last year. The company reported $433.399 thousand in sales this quarter. This is a 35.06 percent decrease over sales of $667.432 thousand the...
06-12 05:16
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference
Nutriband Inc. and its subsidiary Active Intelligence will showcase their expanding AI wellness product portfolio, including new launches like AI Performance Tape, AI Energy Patches, and AI Sleep, at the upcoming ECRM conference in June 2026. The company plans to meet with buyers from major retailers such as Walmart, Amazon, and Cardinal Health to explore national retail opportunities. Nutriband aims to capitalize on growing demand for wellness, ...
05-15 11:00
Nutriband Selects Commercial Brand Name For Abuse-Deterrent Fentanyl Patch; Prepares FDA And Global Trademark Submissions
Nutriband has selected the commercial worldwide brand name for its lead product, an abuse deterrent fentanyl transdermal system, and will submit to the FDA for approval per FDA Guidance.Nutriband partnered with Brand
03-31 04:18
Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
Nutriband Inc. has chosen a global commercial brand name for its abuse-deterrent fentanyl transdermal system and will submit it to the FDA and other regulatory agencies for approval. The company partnered with Brand Institute, Inc., a leader in pharmaceutical brand name development, to ensure the name is safe, unique, and compliant with regulations. The product uses Nutriband’s AVERSA™ technology, designed to prevent abuse and misuse of transderm...
03-30 20:05
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular s...
03-21 01:06
Nutriband Gets Approval To Sell Kinesiology Tapes In Costa Rica
Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that The Costa Rica Ministry of Health has approved the Company's line of Kinesiology Tapes for import and Sale. Innomedica CCB, the company's exclusive
03-18 19:08
Nutriband Signs Exclusive Distribution Agreement With Costa Rica Based Innomedica For AVERSA Fentanyl Upon Approval And All Sports Tape Products Manufactured At Pocono Pharmaceutical / Active Intell Subsidiary
Nutriband Inc. today announced that it has signed an exclusive distribution agreement with Costa Rica Based Innomedica for AVERSA Fentanyl upon approval and all sports tape products manufactured at its Pocono
02-17 20:11
